
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 22, 2021, titled "Dr. Reddy's Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market.".
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 22, 2021, titled "Dr. Reddy's Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market.".
6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories